Jennifer Dole, APRN
Critical Care Medicine · Kankakee, ILNPI 1376892398
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.7% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations.
Across 110 payments — averaging $26.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$665
- Preventric Diagnostics, Inc.$540
- Amgen$259
- AstraZeneca$258
- Johnson & Johnson$156
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$145
- plus $898 from 15 others
What the payments were for
- Travel & lodging$2739%
- Food & beverage$2,64891%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 8 | $665 |
| Preventric Diagnostics, Inc. | 1 | $540 |
| Amgen | 15 | $259 |
| AstraZeneca | 14 | $258 |
| Johnson & Johnson | 9 | $156 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $145 |
| Bayer | 7 | $103 |
| Merck | 6 | $98 |
| Lantheus Medical Imaging, Inc. | 5 | $98 |
| Alnylam Pharmaceuticals Inc. | 5 | $93 |
| Chiesi USA, Inc. | 7 | $93 |
| W. L. Gore & Associates, Inc. | 4 | $84 |
| Esperion Therapeutics, Inc. | 5 | $79 |
| Kiniksa Pharmaceuticals, Ltd. | 5 | $76 |
| Surmodics, Inc. | 2 | $42 |
| Amarin Pharma, Inc. | 2 | $36 |
| Convatec Inc. | 1 | $26 |
| Boehringer Ingelheim | 1 | $21 |
| Novo Nordisk | 1 | $19 |
| Edwards Lifesciences | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,921 in reported general payments places this provider in the 80th percentile of 281 critical care medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amiodarone Hcl | 20 | $184 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $131 |
| Atorvastatin Calcium | 16 | $68 |
| Metoprolol Tartrate | 28 | $61 |
| Furosemide | 25 | $41 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Kankakee
- Brian ReichardtO Fallon$892K
- Michael CutticaChicago$402K
- Daniel DillingMaywood$208K
- Israel RubinsteinChicago$107K
- John RickelmanQuincy$90K
- Abbas Al-QamariChicago$40K
- Husam NayefPalos Park$24K
- Nureain MirzaOak Lawn$22K
- Edward GarrityBurr Ridge$20K
- Fadi AldaasChicago Ridge$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.